Wharton Business Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $252K | Hold |
|
|||||
|
2024
Q2 | $234K | Sell |
|
|||||
|
2024
Q1 | $242K | Hold |
|
|||||
|
2023
Q4 | $247K | Sell |
|
|||||
|
2023
Q3 | $248K | Hold |
|
|||||
|
2023
Q2 | $266K | Hold |
|
|||||
|
2023
Q1 | $272K | Hold |
|
|||||
|
2022
Q4 | $276K | Sell |
|
|||||
|
2022
Q3 | $261K | Hold |
|
|||||
|
2022
Q2 | $256K | Hold |
|
|||||
|
2022
Q1 | $276K | Hold |
|
|||||
|
2021
Q4 | $316K | Hold |
|
|||||
|
2021
Q3 | $332K | Sell |
|
|||||
|
2021
Q2 | $351K | Hold |
|
|||||
|
2021
Q1 | $335K | Hold |
|
|||||
|
2020
Q4 | $318K | Sell |
|
|||||
|
2020
Q3 | $267K | Hold |
|
|||||
|
2020
Q2 | $275K | Sell |
|
|||||
|
2020
Q1 | $221K | Sell |
|
|||||
|
2019
Q4 | $546K | Sell |
|
|||||
|
2019
Q3 | $493K | Hold |
|
|||||
|
2019
Q2 | $557K | Hold |
|
|||||
|
2019
Q1 | $574K | Hold |
|
|||||
|
2018
Q4 | $490K | Hold |
|
|||||
|
2018
Q3 | $619K | Hold |
|
|||||
|
2018
Q2 | $569K | Hold |
|
|||||
|
2018
Q1 | $512K | Sell |
|
|||||
|
2017
Q4 | $529K | Sell |
|
|||||
|
2017
Q3 | $572K | Sell |
|
|||||
|
2017
Q2 | $569K | Sell |
|
|||||
|
2017
Q1 | $591K | Hold |
|
|||||
|
2016
Q4 | $542K | Sell |
|
|||||
|
2016
Q3 | $618K | Hold |
|
|||||
|
2016
Q2 | $545K | Sell |
|
|||||
|
2016
Q1 | $716K | Hold |
|
|||||
|
2015
Q4 | $945K | Sell |
|
|||||
|
2015
Q3 | $860K | Hold |
|
|||||
|
2015
Q2 | $1.1K | Sell |
|
|||||
|
2015
Q1 | $1.24M | Sell |
|
|||||
|
2014
Q4 | $1.16M | Sell |
|
|||||
|
2014
Q3 | $1.09M | Sell |
|
|||||
|
2014
Q2 | $1.04M | Buy |
|
|||||
|
2014
Q1 | $894K | Sell |
|
|||||
|
2013
Q4 | $949K | Sell |
|
|||||
|
2013
Q3 | $1.19M | Sell |
|
|||||
|
2013
Q2 | $998K | Buy |
|